| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |